Research analysts at StockNews.com began coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the ...

Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...

Asthika Goonewardene, an analyst from Truist Financial, has initiated a new Buy rating on BioNTech SE (BNTX).Stay Ahead of the Market:Discover ...

Small-cap healthcare stocks offer a unique opportunity for investors looking to capitalize on innovation and high growth.

Since the European Union's Sustainable Finance Disclosure Regulation came into force in March 2021, asset managers have been required to provide more information on the sustainability risks and ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Top Star rated schemes show high quality schemes which are assigned 5 stars by Value Research, based on different quantitative and qualitative parameters. 5 stars rated schemes are considered as the ...